Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

Bank of America is spending two hundred fifty million dollars per year on GLP-1 drugs for its workforce, per CNBC. These weight-loss medications—which include Ozempic and Wegovy—can cost thousands of dollars annually per patient, and employers across the sector are struggling to keep pace with surging demand.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton